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Abstract
Many neurodegenerative diseases, including Alzheimer’s Disease, are associated with ER
stress. It is suggested that plasma membrane channels contribute to the increased ionic
influx and subsequent cell death in response to ER stress. Pannexin channels, which have
been implicated in various pathophysiological conditions, are a suitable candidate for
facilitating this response. However, mechanisms of pannexin channel activation are
poorly defined. I investigated the potential regulation of pannexin activity by the ER
stress sensor, STIM. It was hypothesized that pannexin channel activation during ER
stress is contingent on the recruitment of STIM proteins. In neurons, pannexin activation
was observed in response to pharmacological ER stressors as well as Aβ42. Moreover, I
identified STIM as a key signaling component promoting pannexin activation under ER
stress in HEK cells, though not in neurons. In conclusion, pannexin activation is coupled
to ER stress in neurons; however, the underlying molecular mechanism remains
unknown.
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Overview of ER stress in neurodegenerative diseases

Many neurodegenerative diseases, including Alzheimer’s Disease (AD), are associated
with the misfolding of proteins, calcium (Ca2+) dysregulation and resultant apoptotic cell
death. Whether these pathological processes are interrelated has remained an open
question. Within a neuron, the organelle responsible for protein folding, and an important
regulator of Ca2+ homeostasis, is the endoplasmic reticulum (ER). In the context of
neurodegenerative diseases, the ER has been shown to have exhausted its capacity to
regulate Ca2+ homeostasis leading to an accumulation of misfolded and unfolded proteins
otherwise known as ER stress. ER stress markers have been found to be up-regulated at
early stages in AD patients. Moreover, ER stress has been proposed to contribute to βamyloid1-42-induced neurotoxicity, however the contributing mechanisms have not been
precisely defined.

Pannexin, a large-pore channel soluble to solutes of up to 1 kDa, has

been implicated in neuronal cell death and is a suitable candidate for studying ER stress
mediated ionic influx. Moreover, a recent study has provided evidence suggesting that
Aβ42 promotes activation of a large-pore channel, though its identity was not confirmed.
Evidence from the Jackson/MacDonald labs suggests that ER stress is associated with
pannexin channel opening. This led us to propose that ER stress may be coupled to
pannexin opening with Aβ42 treatment. In addition, as pannexin activation mechanisms
are poorly understood, I investigated mechanisms by which neuronal ER stress is coupled
to pannexin activation.
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Pannexin channel structure and function

The pannexin channel is a large-pore non-selective ion channel located on the plasma
membrane of neurons. Although pannexin channels were previously reported to localize
to the ER (Penuela et al., 2007), those particular variants of pannexin have been identified
as incomplete-glycosylation forms of pannexin, which fail to escape the ER for
trafficking to the cell surface (Bhalla-Gehi et al., 2010). The ER-retained forms of
pannexin are thought to be destined for premature degradation by proteosomes, a view
that is supported by its co-localization to calnexin, an ER chaperone that retains
misfolded proteins for premature degradation (Gehi et al., 2011). Rather than functioning
as gap junctional hemichannels, pannexins operate individually as bona fide plasma
membrane channels connecting cytoplasm to the extracellular space (MacVicar and
Thompson, 2010). Pannexin-1, first cloned in 2003, is the only ubiquitously expressed
member of the pannexin family (Bruzzone et al., 2003). Pannexin-2 expression is
predominantly confined to tissues of the central nervous system, whereas pannexin-3 is
expressed in skin and bone (Baranova et al., 2004). The ability of pannexin-2 and
pannexin-3 to form functional channels on their own has been debated, however when
co-expressed with pannexin-1, heteromeric channels with their own distinct properties
have been generated (Penuela et al., 2009). Of the three, pannexin-1 is the most studied
to date and the focal point of my experiments.
Structurally, pannexin channels contain 4-transmembrane domains, an intracellular loop,
intracellular N and C termini and highly conserved cysteine residues on two extracellular
loops (Bruzzone et al, 2003).

The original view that pannexins functioned as gap

junction hemichannels stemmed from their topological similarities to the gap junctional

	
  

	
  

	
  

4

Innexin protein family found in invertebrates (Phelan and Starich, 2001). Pannexins have
since been proven not to be gap junctional proteins based on the following conclusive
evidence from various labs:
•

In a paired oocyte assay, transjunctional currents are prominent in connexin
expressing pairs but absent in pannexin expressing pairs (Dahl et al., 1992;
Bruzzone et al., 2003)

•

Pannexin-1 expression has been observed in single non-gap junction forming cells
such as erythrocytes (Locovei et al., 2006)

•

In polarized non-symmetrical cells, pannexin-1 is found exclusively on the apical
membrane which is not involved in cell-to-cell contact (Ransford et al., 2009)

•

In neurons, pannexin-1 is found exclusively at post-synaptic membranes and
shows no sign of involvement in electrical synapses (Zoidl et al., 2007)

With this evidence, pannexins are now widely accepted as large pore forming channels in
the plasma membrane. A single pannexin channel is a hexamer of six subunits that allows
non-selective permeation to ions and small molecules up to 1 kDa in size (Boassa et al.,
2007; Ambrosi et al., 2010).

This large pore size and non-selective permeability

describes the unique nature of pannexin channels.

When describing ion channel

selectivity, channels that are permeable to both cations and anions, pannexin channels for
instance, are considered “non-selective”. In addition to ion transport, pannexin channels
have also been shown to release large metabolites such as ATP, as well as interleukins
and glutamate (Bao et al., 2004; Jiang et al., 2007).

Two important studies have

functionally classified pannexin channels as ATP-release channels, however, an upstream
trigger for pannexin opening remains undetermined.

	
  

ATP release from pannexin-1
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channels serves to induce vasodilation in erythrocytes under hypoxic conditions (Locovei
et al., 2006). Additionally, the same function was noted in apoptotic lymphocytes where
the observed ATP release from pannexin channels serves as a “find me” signal for
macrophages (Chekeni et al., 2010). Given that ER stress markers are elevated in both
apoptosis (Galehdar et al., 2010) and hypoxia (Tajiri et al, 2004), an ER stress triggered
opening of pannexin channels could be a plausible mechanism underlying these
observations.

1.3

Functional identification of pannexin activity

From reviewing literature on pannexin characterization, identification of pannexin-1
channel

activity

involves

a

combination

of

biochemical

assays,

DNA

overexpression/silencing, pharmacological inhibition and electrophysiological recordings.
In addition to the main conductance state, four different sub-conductance states have been
observed in single channel recordings from excised patches in pannexin-1 expressing
oocytes (Bao et al., 2004).

Though not entirely agreed upon, some groups have

characterized pannexin-1 whole cell currents as outward rectifying, activated at
increasingly depolarized potentials (Ma et al., 2009). In this study, to reliably identify
pannexin-1 channel activity and critical mediators in the activation pathway, I have
paired RNA interference (RNAi) and DNA over-expression techniques with
pharmacological characterization during electrophysiological recording of pannexin-1
activity.
Of the variety of known pharmacological inhibitors for pannexin-1, some of these
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compounds overlap in their ability to block various non-selective cation channels (Table
1). For example, pannexin-1 blocker carbenoxolone is also known to block connexin
hemichannels. Additionally, SKF96395, which does not block pannexin-1 channels, is
known to block ORAI and TRPC channels. These inhibitors, among others, are utilized
to pharmacologically identify pannexin-1 currents using a combinatorial approach to
rule-out connexin hemichannels and other non-selective cation channels but rule-in
pannexin channels based on their differential sensitivity to blockers. From the literature,
pannexin-1 activity is inhibited by carbenoxolone (cbx) with an IC50 of 5 µM, and
probenecid (prb) with an IC50 of 150 µM. Contrastingly, pannexin-1 is relatively
insensitive to flufenamic acid (ffa) with an IC50 = 300 µM while connexins are more
sensitive to inhibition by ffa with an IC50 of 3-100 µM but also relatively insensitive to
cbx with an IC50 of 3-100 µM (D’hondt et al., 2009; Ma et al., 2009; Ma et al., 2012).
Despite their effectiveness as an experimental tool, it is important to note that no single
blocker is fully specific to pannexin-1 channels. Thus, employing a combinatorial rulein/rule-out approach to identifying pannexin-1 activity in this study was the best means of
avoiding this potential pitfall.
	
  

	
  

	
  

	
  

Table 1.
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Pharmacological profile of candidate non-selective cation channels

I-V, current-voltage; NMDG+, N-methyl-D-glucamin; La3+, lanthanum, Ca2+, calcium;
ECS, excellular solution; 10panx1, pannexin-1 inhibitory peptide; TRPM, transient
receptor potential melastatin; TRPC, transient receptor potential cation; CRAC, calcium
release-activated calcium

One overlying objective of this project was to provide insight and rationale for exploring
a role of pannexin channels in ER stress associated neurodegeneration. Since both
pannexin channels and ER stress have individually been shown to contribute to cell death
in a variety of cell types, including neurons, this study included experiments to determine
whether pannexin channels were activated in response to treatment with Aβ42, a known
inducer of ER stress.
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Regulation of Ca2+ homeostasis by the ER

The ER is a known regulator of intracellular signaling events, most notably intracellular
Ca2+ homeostasis. When a cell exhausts its capacity to regulate intracellular Ca2+, normal
functions are lost and cell death proceeds (Orrenius et al., 2003). Morphologically, the
ER extends from dendritic spines, across the cell body, down the axon to the pre-synaptic
terminal, which suggests an existing ER contribution to neurotransmitter release and gene
transcription among other cellular functions (Verkhratsky and Peterson, 2002). Aside
from Ca2+ homeostasis, the ER serves many other well-characterized functions including
post-translational protein processing as well as the facilitation of protein folding and
transport (Burdakov et al., 2005). Correct folding of newly synthesized proteins is aided
by several ER chaperone proteins, most commonly binding-immunoglobulin protein
(BiP), a heat shock protein family member.

Other notable ER chaperones include

protein-disulfide-isomerase, calnexin and calreticulin. Once folding is complete, the
functional proteins are transported from the ER to the golgi complex (Truettner et al.,
2009).

Since ER chaperones are Ca2+ dependent, their activity is dictated by the

intraluminal Ca2+ concentration of the ER (Michalak et al., 2002).

Therefore,

dysregulation of ER Ca2+ stores and consequent impairment of ER chaperone function,
results in an accumulation of unfolded and misfolded proteins. This disturbance in
protein folding characterizes a condition called ER stress (Ryu et al., 2002), a cellular
correlate to the progression of neurodegenerative diseases. In fact, the occurrence of
cellular stressors that disrupt ER function increases with aging. For example, elevated
intracellular Ca2+ and reactive oxygen species can alter the balance of the cellular redox
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environment to induce ER stress. This trend indicates that the aging brain is more
susceptible to ER stress associated neuronal injury (Banhegyi et al., 2008).

1.5

Cellular responses to ER stress

An early cellular response to ER stress is the activation of a pro-survival mechanism that
is a network composed of intracellular signaling and transcriptional changes known as the
Unfolded Protein Response (UPR). This biochemical cascade involves the coordinated
activity of specific enzymes and transcription factors that alter conditions within the ER
in an attempt to restore Ca2+ and protein homeostasis. The prevailing actions of the UPR
are to attenuate the rate at which mRNA is translated, up-regulate the expression of ER
resident chaperones and foldases, mediate the expansion of the ER membrane to increase
ER compartment space, and trigger ER-associated-degradation to eliminate misfolded
proteins (Calfon et al., 2002). Under severe or chronic ER stress, the UPR can stimulate
an inflammatory signaling pathway and ultimately apoptosis when pro-survival efforts
are exhausted (Harama et al., 2009). In cases of ER stress where homeostasis can not be
restored and the signaling pathways of the UPR subverts from pro-survival to proapoptotic, fluorescent dyes have been used to monitor the well characterized increase in
plasma membrane permeability observed in apoptotic cells (Puthalakath et al., 2007).
Given the large pore size and non-selective permeability of pannexin channels, it is
reasonable to consider them as the ion channel facilitating this observed response to ER
stress.
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ER stress markers that are commonly assayed for include the active, dimerized forms of
PERK, IRE1 and ATF6 as well as upregulated ER stress responsive genes CHOP and
other protein folding chaperones. For the purpose of my thesis, ER stress markers and
the signaling pathways of the UPR did not represent the focus of my experimental plan
and are therefore not discussed in further detail. Rather, the focus of my study was on the
signaling of ER stress to the plasma membrane where a response of ion channel activity
could be recorded.

1.6 Store-Operated Ca2+ Entry, Stromal Interacting Molecules
A recurring theme in many studies of ER stress is that depletion of ER Ca2+ stores is an
important trigger for ER stress. This can be enhanced through activation of ryanodine
receptors and IP3 receptors on the ER, or conversely, the impairment of sarcoplasmicendoplasmic reticulum ATPase (SERCA) function. Experimentally, depletion of ER
stores through inhibition of SERCA activity is sufficient to initiate ER stress and cell
death (Stutzmann and Mattson, 2011). Typically, ER stress is defined on the basis of
UPR induction. However, UPR signaling is unlikely to represent the earliest response of
the ER to cellular stressors, which includes depletion of ATP, loss of Ca2+ homeostasis
and the generation of reactive oxygen species (ROS) (Kohno et al., 1994; Xing et al.,
2004). ER chaperones and foldases being Ca2+ dependent makes correct protein folding
in the ER contingent on luminal Ca2+ levels being maintained by steady refilling
processes, thus avoiding activation of ER stress pathways.
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Stromal-interacting molecules (STIM) proteins, which function as ER resident Ca2+
sensors, have recently been identified as important contributors to neuronal cell death
post-ischemia where ER stress has been shown to occur and proceed to pro-apoptosis
(Berna-Erro et al., 2009). In the mid-1980s, it was proposed that when ER stores are
depleted of Ca2+, a refilling process via Ca2+ influx from the extracellular environment,
involving ER proteins and plasma membrane channels, is utilized (Putney, 1986). This
process has been termed store-operated Ca2+ entry (SOCE), alternatively referred to as
capacitive calcium entry (CCE). Two STIM isoforms (STIM1 and STIM2) have recently
been shown to act as Ca2+ sensors that relay messages of alterations in luminal Ca2+ to the
plasma membrane (Liou et al., 2005). Their direct interaction with Ca2+ influx channels
at the plasma membrane is required for SOCE (Zhang et al., 2006).

1.7

STIM structure and function

The single-pass transmembrane proteins STIM1 and STIM2, originally named GOK and
proposed to be involved in tumor suppression and modifications of cell morphology
(Sabbioni et al., 1997), have a cytosolic C-terminal, whereas the N-terminal, responsible
for Ca2+ detection, is in the ER lumen where Ca2+ is stored. Functionally, STIM detects
decreases in ER-luminal Ca2+ through Ca2+ binding EF-hand domains on the
aforementioned luminal N-terminal. At resting state, defined by a sufficient level of ERluminal Ca2+, the binding of Ca2+ to the intraluminal EF-hand domains of the N-terminal
maintains STIM in its resting-dimeric conformation. Also at the N-terminal are dense
clusters of sterile-α-motif (SAM) domains that function to stabilize STIM in a dimeric
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form when EF-hands are Ca2+ bound (Stathopulos et al., 2006). In the case of depleted
Ca2+ stores, Ca2+ dissociates from the EF-hand domains of STIM, unfolding and
destabilizing the EF-SAM clusters. This promotes activation, wherein STIM dimers
aggregate into oligomeric STIM complexes (Stathopulos et al., 2008). Effectively, STIM
behaves as a Ca2+ sensor and is responsible for relaying the status of ER Ca2+ stores to the
plasma membrane. Translocation of STIM along the ER membrane to ER-PM junctions
enables STIM interaction with Ca2+ influx channels expressed at the cell surface to
facilitate SOCE.

The two isoforms, STIM1 and STIM2, possess homologous functional domains with the
only differences between the two isoforms being slight variations in the amino acid
sequences of their N and C termini. Functional consequences of these variations are in
their affinities for Ca2+ binding, thus affecting each isoform’s sensitivity of ER Ca2+
detection as well as activation kinetics and contribution to SOCE signaling (Zhou et al.,
2009). The higher affinity isoform, STIM1, is regarded as the principal modulator of
SOCE because it is rapidly activated under ER Ca2+ depletion (Roos et al., 2005),
whereas the lower affinity STIM2, despite being more sensitive to ER Ca2+ depletion,
demonstrates slower activation kinetics and is considered to be responsible for the very
fine-tuning of ER Ca2+ concentrations (Brandman et al., 2007).

Aside from sensing decreases in ER Ca2+ levels, STIM has also been regarded as a
general cellular stress sensor because it is also activated by oxidative stress and transient
temperature changes (Soboloff et al., 2012). In response to pathological ROS levels, S-
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glutathionylation of Cys56 on STIM, adjacent to its EF-SAM domains, causes a
dissociation of Ca2+ from STIM and subsequent SOCE without ER Ca2+ depletion
(Hawkins et al., 2010). Additionally, STIM1 has been shown to oligomerize and
translocate to ER-PM junctions when cells are heated from 37 to 40oC. Subsequent
cooling back to 37oC triggers Ca2+ influx, independent of ER Ca2+ levels, thus
implicating STIM as a sensor to transient temperature change as well (Xiao et al., 2011).
So far, members of the ORAI, TRPC and L-type voltage-gated Ca2+ channel families
have been identified as coupling targets for activated STIM (Feske et al., 2006; Huang et
al., 2006; Wang et al., 2010). Given that, the pannexin family of ion channels has been
pathophysiologically implicated in various cellular responses associated with ER stress
such as hypoxia, ischemia and apoptosis (Dahl and Keane, 2012), STIM is a suitable
candidate to consider for coupling ER stress to pannexin channel activation (Fig.1.1).
The focus of my thesis is to investigate the relationship between STIM and pannexin
channels in the context of ER stress induced pannexin activation.
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Figure 1.1
Proposed model of ER stress coupled pannexin activity, mediated by
activate STIM proteins.
A) At physiological levels of ER-Ca2+, STIM (yellow) remains in resting state as their
intraluminal E-F hands bind Ca2+, stabilizing the structure. B) ER-Ca2+ depletion and
subsequent accumulation of misfolded proteins in the ER, by inhibition of SERCA
pumps for example, results in the dissociation of Ca2+ from STIM. Active STIM proteins
will oligomerize and translocate to ER-PM junctions to interact with plasma membrane
ion channels through their CAD domains (purple).
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ER stress in Alzheimer’s Disease, beta-amyloid

Neurodegenerative diseases share common pathological features such as the
accumulation of misfolded proteins and loss of Ca2+ homeostasis. For this reason, ER
stress is often studied in the context of neurodegeneration. In particular, ER stress has
been well defined in models of Alzheimer’s disease (AD), a fatal neurodegenerative
disease characterized by progressive dementia and memory loss. Miscleavage of the
amyloid precursor protein in the brain by the gamma-secretase enzyme yields a
neurotoxic species, beta-amyloid1-42 (Aβ42).

A long held view suggests that the

deposition of Aβ42 into senile plaques, the hallmark of an Alzheimer’s brain at autopsy, is
largely responsible for neurodegeneration. However, plaque formation represents the
endpoint of an aggregation process which leads to the formation of soluble oligomers,
protofibrils and fibrils. Importantly, recent studies suggest that the onset of cognitive
decline in patients is better correlated with the occurrence of soluble oligomers rather
than plaques (McLean et al., 1999; Mc Donald et al., 2010). Accordingly, a recent focus
has been to understand the mechanisms responsible for neurotoxicity induced by soluble
oligomers of Aβ42, rather than the formation of plaques, and more specifically, to identify
ion channel coupling downstream of Aβ42, a known inducer of ER stress.

Various

neurodegenerative

diseases,

including

AD,

Parkinson’s

Disease

and

Huntington’s Disease, are associated with an accumulation of misfolded proteins causing
a disruption in ER function, and in turn inducing ER stress (Urano et al., 2000; Imai et
al., 2001; Holtz and O’Malley, 2003; Kaneko et al., 2010). In the context of AD at the
cellular level, oligomers of Aβ42 disrupt Ca2+ homeostasis by altering the function of
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ryanodine receptors and IP3 receptors on the ER membrane as well as various calcium
permeable channels on the plasma membrane including voltage-gated Ca2+ channels,
nicotinic acetylcholine receptors and glutamatergic receptors (reviewed by Demuro et al.,
2010). thereby causing ER stress and ultimately increasing neuronal vulnerability to
apoptosis. Other cellular stresses brought on by oligomers of Aβ42 include increased
oxidative stress, disruption of synaptic plasticity, and altered synaptic structure
(Townsend et al., 2006; De Felice et al., 2007). Although, the mechanisms responsible
for such changes are not well understood recent evidence suggests that Aβ42 may
compromise neuronal viability by disrupting the function of the endoplasmic reticulum,
leading to ER stress. In AD studies, application of Aβ42 has been shown to increase the
expression of ER stress responsive genes (Takahasi et al., 2009) and ER stress markers
are detected at the early stages of AD in patients (Hoozemans et al., 2005; Unterberger et
al., 2006). Importantly, previous studies have shown that protecting the ER against stress
attenuates Aβ42-mediated neurotoxicity (Lee do et al, 2010). In behavioural studies,
protection from ER stress has been shown to attenuate memory loss in mouse models of
AD (Ricobaraza et al., 2010; Wiley et al., 2011).

1.9

Rationale and hypothesis

Preliminary studies from our lab strongly imply that pannexin channels are activated
downstream of ER stress. In these experiments, ion currents were characterized through
whole-cell voltage-clamp recordings from pyramidal CA1 hippocampal neurons exposed
acutely to commonly used ER stressors.

	
  

Thapsigargin (Tg) and cyclopiazonic acid
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(CPA), although different in structure, are both sarcoplasmic-endoplasmic-reticulumCa2+-ATPase (SERCA) inhibitors which were applied to neurons to prevent depleted ER
Ca2+ stores from being replenished, effectively inducing ER stress (Nguyen et al., 2002).
Furthermore, neurons were exposed to tunicamycin (Tn), an inhibitor of N-glycosylation,
which decreases the post-translational protein processing typically facilitated by the ER
(Shiraishi et al., 2005). The consequent accumulation of unprocessed proteins in the ER
initiates ER stress. The observed current was classified as emanating from pannexin
channels on the basis of biophysical and pharmacological profiles. Supporting our view
was the inhibition of this ER stress-induced current by known pannexin blocking agents
such as lanthanum (La3+), carbenoxolone, probenecid and

10

panx-inhibitory peptide, as

well as its insensitivity to ORAI and TRPC blocker SKF96365 and removal of Ca2+ from
extracellular solution. What remained to be identified is a mechanism responsible for
activating pannexin channels in response to ER stress.

One candidate mechanism

through which an ER stress signal is relayed to pannexin channels expressed at the cell
surface is via coupling with ER-resident STIM proteins, an essential contributor to the
refilling of ER Ca2+ stores upon depletion.

The primary objective of my thesis was to establish the mechanisms through which ER
stress provokes pannexin activation. I hypothesize that pannexin channel activation
during ER stress is contingent on the recruitment of STIM proteins.
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Preparation of primary cultured mouse hippocampal neurons

All postnatal hippocampal cell cultures were prepared by technicians from the
Jackson/MacDonald lab as previous described (MacDonald et al., 1989).

In short,

embryonic mouse pups were harvested at embryonic day 17-18, and the hippocampi of
each were dissected and isolated. Neurons were dissociated by mechanical trituration
using pasteur pipettes and the cells were plated on poly-D-lysine coated petri dishes at a
plating of density of approximately 50% confluency, approximately 1 million cells per
plate. These cultures were incubated in neurobasal culture media, supplemented with B27 and glucose, at 37oC in 5% carbon dioxide. Media was replenished every 3-4 days.
Electrophysiological recordings were performed on cultured hippocampal neurons after
14-21 days in vitro (DIV).

Knockdown of STIM1 and STIM2 was conducted using lentivirus to infect cultured
hippocampal neurons with STIM1 shRNA and/or STIM2 shRNA or scrambled shRNA
as control. Expression of the shRNA was driven by a u6 promotor. Also expressed on
the same transfer vector, pLB, was green florescent protein (GFP), which was driven by a
CMV promotor.

Infecti was performed on cultured neurons 3-5 DIV and

electrophysiological recordings were performed 14-21 DIV.

2.2

Preparation of pannexin and STIM expressing HEK 293 cells

A cell line of HEK 293 cells stably expressing a tetracycline-inducible pannexin-1
encoding gene “flag-mPanx1”, generated by the Jackson lab, was passaged bi-weekly.
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Cells were cultured in 100 mm petri dishes and grown in FBS enriched D-MEM,
incubated at 37oC in 5% carbon dioxide. Transient co-transfections of DNA expression
plasmids for STIM1 and/or STIM2 as well as GFP were performed on flag-mPanx1 HEK
293 cells using the JetPrime transfection system (Polyplus) prior to electrophysiological
recording. To control for the contribution of endogenous STIM expression in some
experiments, RNA-silencing vectors targeting STIM1 and STIM2 were also transfected.
For

experiments

involving

mutated

STIM

proteins,

DNA

expressing

an

ezrin/radixin/moesin (ERM) domain deleted variant of STIM1 (STIM1ΔERM) was used
(Fig. 2.1). Briefly, flag-mPanx1 HEK 293 cells were seeded in 6-well plates, 24 hours
prior, to yield optimal transfection confluence of 60-80%. Transfection mixes were
composed of 200 µL JetPrime buffer, 2 µg total DNA, 2.5 µL JetPrime transfection
reagent. 2 µg of total DNA to be transfected included combinations of DNA vectors
encoding GFP, STIM1 (in pCDNA3.1), STIM2 (in pCDNA3.1), shRNA targeting
STIM1 expression “pLB(mCherry)-mSTIM1-hp4”, shRNA targeting STIM2 expression
gene “pLB(GFP)-mSTIM2-hp4”, a mutated variant STIM1ΔERM (in pIRES) and empty
vector “pCDNA3.1” (Invitrogen).

Transfection mixes were incubated at room

temperature for 10 minutes, vortexed for 10 seconds, and added drop wise to flagmPanx1 HEK 293 cells. Following 4 hours of incubation at 37oC in 5% carbon dioxide,
transfection media was replaced with fresh media. Cells were re-seeded on 35 mm petri
dishes 24 hours post-transfection at a plating density of 20% for next-day recording or
10% for day-two recordings. Upon plating, 1 µg/mL doxycycline was added to media to
induce pannexin-1 expression.
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Figure 2.1
Representation of the full length STIM1 protein (above) and the ERM
domain deletion in STIM1ΔERM variant (below).
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Preparation of oligomeric Aβ42 peptides

Solid Aβ42 peptides (rPeptide, catalogue no. A-1002-2) stored at -80oC, were equilibrated
to room temperature before hexaflouro-2-propanol (HFIP) solvent was added, on ice, to a
peptide concentration of 1 mM. After 1 hour of incubation at room temperature with
intermittent vortexing to achieve complete dissolution, peptide solutions were placed
back on ice for 5-10 minutes. Aβ42 solution was aliquoted in 10 µL samples and HFIP
solvent was removed by Speedvac dry down for 10 minutes at 37oC, then placed in -20oC
for 2 hours, followed by storage at -80oC leaving only peptide biofilms of Aβ1-42
monomers. To oligomerize, fresh anhydrous DMSO was added to a concentration of 1
mM Aβ42 and vortexted, yielding a final concentration of 100 µL.

Solutions were

sonicated for 10 minutes at 37oC then diluted 10-fold in PBS and mixed well. Final
incubation at 4oC for 24 hours is when oligomerization occurred yielding soluble
oligomers of Aβ42, stable at -80oC for up to 2 weeks.
Application of soluble oligomers of Aβ42 to primary hippocampal neuron cultures was
done 24 hours prior to electrophysiological recording at a final peptide concentration of 1
µM in media and incubated at 37oC in 5% carbon dioxide.

2.4

Electrophysiology: whole-cell patch-clamp recordings

Pyramidal hippocampal neurons were identified under a microscope by cell shape, with
candidate neurons having a triangular shaped cell body, phase-bright contrast, and
healthy re-formed non-fractioned processes (Fig. 2.2). For HEK cells, UV light exposure
to excite fluorescence in successfully transfected cells was used to visually identify
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candidate cells with expression of pannexin-1 and STIM based on GFP and/or Cherry coexpression. Petri dish media was replaced with artificial extracellular solution containing
(in mM): 130 NaCl, 25 HEPES buffer, 10 D-Glucose, 10 tetraethylammonium (TEA), 5.4
KCl, 2 CaCl2 and 1 MgCl2 adjusted to pH 7.4 with NaOH. The following channel
blockers were included in recordings of neurons only (in µM): 500 4-aminopyradine (4AP), 0.2 tetrodotoxin (TTX), 50 CdCl2, 10 bicuculline, 10 cyano-nitroquinoxaline-dione
(CNQX), 10 nifedipine. Final osmolarity was adjusted to 305-315 mOsm. Depending on
experimental conditions, extracellular solutions would also contain either 3 µM
thapsigargin (Tg) or 100 µM lanthanum (La3+) to evoke pannexin currents or block the
channel respectively.
A two-stage pipette puller (Narishige PC-10) was used to make borosilicate glass
capillaries under heat to form the patch pipette.

The patch pipette was filled with

intracellular solution containing (in mM): 130 K-Gluconate, 10 ethylene glycol
tetraacetic acid (EGTA), 10 HEPES buffer, 10 KCl, 5 TEA, 4 MgATP, 2 MgCl2, and 1
CaCl2 adjusted to pH 7.3 with KOH and osmolarity 295-305 mOsm. The centre of the
cell body was approached with a patch electrode of 4-6 MΩ of resistance in solution.
Upon approaching the cell, negative pressure was applied to the patch pipette to seal onto
the cell membrane. The holding voltage was clamped at -60 mV to mimic the resting
membrane potential of a neuron and negative pressure was gently increased until a 1 GΩ
seal was achieved. To break through the membrane, while maintaining a tight seal, 0.1 cc
of negative pressure was gently re-applied together with a 2 kHz pulse for 0.6 ms. Upon
break-through the inner contents of the cell are continuous with the intracellular solution
of the patch pipette. Recording protocol, either acute-response (section 2.4.1) or chronic-
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response (section 2.4.2), could then be initiated. Traces were recorded using Axoscope
and Clampex softwares (Molecular Devices).
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A)

B)

C)

D)

Figure 2.2
Experimenter’s view of cells during patch-clamp recordings.
A) Pyramidal hippocampal CA1 neuron viewed under phase contrast. B) Pyramidal
neuron in whole-cell patched configuration with micropipette. C) Pannexin-1 inducible
HEK 293 cells, transfected with GFP tagged STIM. D) Transfected HEK 293 cell in
whole-cell patched configuration with micropipette.
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Recording acute-response pannexin currents

A shifting multi-barrel perfusion system was loaded with 1) control extracellular solution
2) extracellular solution containing ER stress inducing compound 3) extracellular
solution containing pannexin channel blocker (Fig. 2.3). Barrels were positioned to
achieve a flow rate of 1 mL/min. Upon break-through of the cell membrane, control
barrel was allowed to flow for the duration of a 2-5 minutes stable baseline recording.
Initial break-through leak currents of less than -300 pA were considered healthy. Flow
was then switched to the ER stress inducing solution barrel for either a 20-minute
duration or the development of a characteristic pannexin current. Flow was finally
switched to the pannexin blocker solution barrel until either baseline current was reestablished or no further decrease in current was made. Traces were analyzed for peak
current, residual current after block and/or total charge transfer depending on the
objective of the experiment.

Figure 2.3
Representation of extracellular solution application via a shifting
barrel perfusion system in close proximity to the patched neuron
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Recording chronic-response pannexin currents

For experiments where acute application of the inducing compound was insufficient in
evoking pannexin currents, cells were pre-treated for 24 hours to mimic chronic
application. Recording of chronic responses were performed on neurons 24 hours pretreated with 1 µM oligomers of Aβ1-42. Barrel perfusion system was loaded with 1)
control extracellular solution 2) extracellular solution containing pannexin channel
blocker. Barrels were positioned to achieve a flow rate of 1 mL/min. Recording was
started upon gigaseal of patch electrode to cell membrane, prior to break-through. Initial
current at the time of break-through was recorded and maintained for 2-5 minutes before
flow was switch from control to pannexin blocker solution until either baseline current
was re-established or no further decrease in current was made. Traces were analyzed for
initial/constitutive current and percentage block of response.

2.5

Statistical analysis

Clampex and Clampfit (Molecular Devices) softwares were used to extract raw data. All
data values reported are expressed as ± standard error. Statistical analysis was conducted
using GraphPad Prism 5 (GraphPad Software, CA). Unpaired t-test was used to compare
parameters of channel activity between treatment groups. Multiple groups were analyzed
by ANOVA with Tukey’s post hoc test. For all statistical tests, P<0.05 was considered
significant.
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Sources of drugs, reagents and peptides

The sources of drugs, reagents and peptides used in this study are from the following
suppliers:

Bishop Canada

KCl, HEPES, EGTA

Enzo Life Sciences

zVAD-FMK

Invitrogen

Thapsigargin, Neurobasal Culture Medium, B-27

Pfizer

Doxycycline

Polyplus

JetPRIME

rPeptide

Aβ1-42, Aβscrambled

NaCl, K-Gluconate, D-Glucose, CaCl2, MgCl2, TTX, TEA, 4-AP,
Nifedipine, CdCl2, Mg(ATP)2, La3+, Probenecid, Carbenoxolone,
Sigma-Aldrich
Dulbecco’s Modified Eagle Medium, Fetal Bovine Serum, HFIP,
PP2, DMSO
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ER stress induces pannexin activation

My first set of experiments was designed to show a relationship between ER stress and
pannexin channel activity. Upon successful patching of a healthy candidate cell
(described in section 2.4), recording started with 2-3 minutes of exposure with control
solution to establish a stable baseline. Thapsigargin, an ER stress inducer by SERCA
pump inhibition, at 3 µM in extracellular fluid (ECF) was applied via barrel perfusion
system to the patched neuron. In neurons, inward currents indicative of pannexin channel
activation developed 10-15 minutes into thapsigargin application.

The rate of ECF

perfusion was 1 mL/min in all experiments. The evoked inward currents were rapidly
blocked by perfusion of 100 µM lanthanum, a reversible blocker of pannexin channels.
Reversibility of lanthanum is exhibited by the onset of a large inward current upon
washout of lanthanum with control ECF perfusion. Under these conditions, pannexin
currents were recovered within seconds (Fig. 3.1A). Thapsigargin evoked pannexin
currents were highly reproducible and the sensitivity to lanthanum blockade could be
repeated so long as blocker was applied while the cell remained healthy/responsive.
Indeed, if the sustained large inward pannexin current were continued for a longer
duration, the health of the cells would deteriorate at which time lanthanum could no
longer block the much larger currents observed. Therefore, lanthanum ECF was generally
applied when developing inward currents either plateaued or reached -2500 to -3000 pA.

In neurons, pannexin currents, identified by their pharmacological sensitivity, were
evoked upon treatment with 3 µM thapsigargin ECF (-3010 ± 641 pA, n=4), whereas
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pannexin currents did not develop under control ECF (-122 ± 29 pA, n=4) (P=0.0041)
(Fig. 3.1C). This serves as a demonstration of ER stress induced pannexin activation.

These results are consistent with recent findings from the Jackson/MacDonald lab
illustrating pannexin activation in response to various ER stress inducers, namely
thapsigargin and cyclopiazonic acid, both SERCA inhibitors, as well as tunicamycin, an
inhibitor of N-glycosylation (Appendix A Fig. S1A).

Characterization of pannexin

current was previously done in the Jackson/MacDonald lab using a combinatorial
approach to rule-in and rule-out candidate non-selective cation channels.

Current

sensitivity to known pannexin blockers lanthanum, carbenoxolone, probenecid and 10panx
peptide ruled-in pannexin channels. Insensitivity to SKF96365 (ORAI/TRPC channel
blocker) and Ca2+-free solution (inhibits TRPM/connexin channel activation) further
demonstrated the current to be pannexin mediated (Appendix A S1B).
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Figure 3.1. Pharmacological ER stress inducers evoke pannexin activation in
hippocampal CA1 neurons.
A) Representative trace of whole-cell patch clamp recording from hippocampal CA1
pyramidal neuron. Inward current develops in response to acute treatment of extracellular
solution containing 3 µM thapsgargin (Tg). Current is reversibly blocked by 100 µM
lanthanum (La3+) solution. Horizontal bars indicate drug application periods. Voltage
was clamped at a holding potential of -60 mV. B) Summary bar graph showing averaged
peak currents (pA) under application of control ECF, 3 µM thapsigargin containing ECF
and 100 µM lanthanum containing ECF in neurons (n=4). C) IV curve, taken at the peaks
of currents recorded under Tg were linear, over the voltage range -50 to 100 mV, and
reversed at 0 mV, consistent with the IV characteristics of pannexin currents. Values are
represented as mean ± SEM. Statistical analysis: unpaired Student’s t-test, P < 0.05.
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Aβ42 induced pannexin activation in neurons

Given previous findings that ER stress is associated with various neurodegenerative
diseases, I explored the possibility that Aβ42 treatment of neurons, known to trigger ER
stress (Chefekar et al., 2007), could promote pannexin channel activation. I conducted
this experiment in hippocampal CA1 pyramidal neurons, knowing that the hippocampus
is important for learning and memory and especially vulnerable to injury in Alzheimer’s
Disease patients (Troncoso et al., 1996). I first examined the effects of acute Aβ42
application during recordings from cultured CA1 neurons. No current was evoked during
60 minutes of constant perfusion of 1 µM Aβ42 in ECF (Fig. 3.2A). This negative finding
was not unexpected since Aβ42 is not thought to target the ER directly, unlike
thapsigargin for instance, and therefore likely requires a more chronic treatment with
Aβ42.

The consequence of chronic Aβ42 treatment was therefore examined next in

neurons pre-treated with 1 µM Aβ42 for 24 hours. Recording began immediately after
forming a seal onto the cell membrane with a resistance greater than 1 gigaohm, but
before breaking through the membrane (Fig. 3.2B). 24 hour pre-treatment with Aβ42
resulted in large inward current, consistent with known pannexin pharmacology.
Pannexin currents were not observed in vehicle and scrambled Aβ42 peptide groups
(P<0.05) (Fig. 3.2C).

These pannexin currents were seen immediately upon

breakthrough of the cell membrane, as opposed to developing over minutes as previously
seen under thapsigargin treatment, indicative of constitutive pannexin activation in
response to chronic (24 hour) Aβ42 treatment.
Control experiments were done using vehicle (0.1% DMSO) treatment and a scrambled
Aβ peptide. This ensured that the result was an effect of Aβ42, rather than a non-specific

	
  

	
  

	
  

34

effect of applying a peptide extracellularly. These characteristic pannexin currents were
not observed in recordings from either control group (Fig. 3.2C).
To confirm the oligomerization of Aβ42, the Jackson/MacDonald lab has tested the final
product by western blot (Appendix A Fig. S2).
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Figure 3.2. Effect of 24 hour extracellular pre-treatment of 1 µM Aβ42 oligomers
on pannexin currents in whole-cell voltage-clamp recordings from hippocampal
CA1 pyramidal neurons.
A) Lack of current in a recording of acute treatment of 1 µM Aβ42. B) Representative
trace of pannexin current from a neuron 24 hours pre-treated with 1 µM Aβ42. C) In the
group treated with 1 µM Aβ42 oligomers, constitutive pannexin currents were observed at
the point of gaining whole-cell access. These constitutive currents were lanthanum
sensitive in the Aβ42 group and significantly larger than control groups. Pre-treatment
with vehicle (0.1% DMSO) as well as scrambled versions of the Aβ42 peptide did not
produce pannexin currents. Voltage was clamped at holding potential -60 mV. Values
are represented as mean ± SEM. Statistical analysis: one-way repeated-measures
ANOVA with Tukey’s post-hoc test. Identical letters (a, b) indicate no significant
difference between groups (P < 0.05).
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ER stress induced pannexin-1 activity is modulated by STIM proteins

To identify a molecular mediator in the pathway coupling ER stress to pannexin
activation, I investigated the role of the ER stress sensor, STIM, in modulating pannexin
currents. I used a mammalian recombinant expression system allowing me to overexpress
the proteins of interest, pannexin-1 and STIM. The experimental design was as follows;
recordings were performed from HEK 293 cells transiently transfected with pannexin-1
alone (absence of STIM) along with full-length STIM or a mutated variant of STIM. The
mutated STIM (STIM1ΔERM) possessed a domain deletion such that the ERM domain,
which has been shown as the critical domain in ER stress induced ORAI channel
activation, was deleted as illustrated in Fig. 2.1 of methods section.
From whole-cell voltage-clamp recordings, application of 3 µM thapsigargin to HEK
cells expressing full-length STIM1 evoked a characteristic pannexin current. Consistent
with the known pharmacological sensitivity of pannexin channels and evoked large
inward currents during 3 µM thapsigargin application (-2383 ± 329 pA, n=3). In the
absence of thapsigargin, under the perfusion of control ECF, comparable currents were
not observed (-73 ± 49 pA, n=3) (P=0.0023) (Fig. 3.3B). In contrast, large currents in
response to thapsigargin were not observed in the absence of STIM. This is consistent
with previous unpublished results from the Jackson/MacDonald lab where thapsigargin
did not evoke large pannexin currents in HEK cells that were transfected with pannexin-1
only. Large pannexin currents could only be recorded when co-transfecting either STIM1
or STIM2 along with pannexin-1 (Appendix A Fig. S3). This suggests STIM is required
for pannexin activation in response to thapsigargin.
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Next, I examined the effects of 3 µM thapsigargin application to HEK cells expressing a
mutated variant of STIM, STIM1ΔERM. In contrast to cells expressing full length
STIM1, thapsigargin did not evoke pannexin currents in cells expressing the truncated
STIM variant (-585 ± 329 pA, n=6) (P=0.12) (Fig. 3.3C). In summary, when comparing
the peak currents evoked by thapsigargin between STIM1 and STIM1ΔERM groups, the
current is significantly larger in the STIM1 group (p=0.0113) (Fig. 3.3D).
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modulation of ER stress induced panx1 current
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Figure 3.3. Effect of ERM-domain deletion from full-length STIM on ER stress
induced pannexin-1 currents in whole-cell voltage-clamp recordings from HEK 293
cells transiently transfected with pannexin-1 and either full-length or mutated
STIM1. A) Representative traces of whole-cell patch clamp recordings from transiently
transfected HEK 293 cells overexpressing pannexin-1 and either full length STIM1,
mutated STIM1 with deletion of the ERM domain or empty vector ie. no expression of
STIM1. Horizontal bars indicate drug application periods. Summary bar graph showing
peak current (pA) under application of control ECF, 3 µM thapsigargin-containing ECF
and 100 µM lanthanum-containing ECF with overexpression of B) full length STIM1
(n=3) and C) mutated STIM1 (n=6). D) Comparison of peak current between full length
STIM1 and mutated STIM1 during thapsigargin treatment. Voltage was clamped at
holding potential -60 mV. Values are presented as mean ± SEM. Statistical analysis:
unpaired Student’s t-test, P < 0.05.

	
  

	
  
3.4

	
  

41

ER stress evoked pannexin current is not STIM-dependent in neurons

After observing ER stress induced pannexin activation in both neurons and HEK cells,
followed by evidence of this response being STIM-dependent in HEK cells, the next step
was to determine if pannexin activation in neurons also required STIM. This would
establish a mechanism for coupling ER stress to pannexin activation in neurons and
provide a candidate mechanism for the aforementioned Aβ42 induced pannexin activation.
To investigate STIM-dependent pannexin activation in neurons, I recorded ER stress
induced pannexin currents from hippocampal CA1 pyramidal neurons where expression
of STIM1 and STIM2 was knocked down after 14-16 days of lentiviral transduction with
shRNA sequences targeting STIM1 and STIM2. Fluorescent tags, GFP for STIM1 and
mCherry for STIM2, were expressed on the same vector as the shRNA sequences. This
allowed for visual identification and selection of infected neurons for whole-cell
recordings.
To evaluate the effectiveness of the shRNA in knocking down expression of the proteins
of interest, the Jackson/MacDonald lab performed western blots assaying for levels of
STIM1 and STIM2 using whole-cell protein extracts 14-16 days post-infection with
shRNA. Levels of STIM1 and STIM2 were quantified densitometrically and normalized
to β-actin. Results show that the expression of STIM1 and STIM2 was effectively
knocked down by 70-90% from control levels by their respective shRNA target
sequences (Appendix A S4).
When comparing peak currents, evoked by 3 µM thapsigargin, between the STIM
knockdown group (-1685 ± 292 pA, n=5) and the control group (-2016 ± 200 pA, n=6),
no significant difference was observed (P=0.3620) (Fig. 3.4A). In the same recordings,

	
  

	
  

	
  

residual current remaining after 100 µM lanthanum was also analyzed.
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STIM

knockdown group (-487 ± 192 pA, n=5) and control group (-560 ± 167 pA, n=6) showed
no significant difference (P=0.7749) (Fig. 3.4C). Another parameter analyzed was total
charge transferred across the membrane, for the duration of the thapsigargin application,
as measured by the area under the curve (i.e. time integral of membrane current). No
significant difference was observed between STIM knockdown (-216 ± 46 pA, n=5) and
control group (-237 ± 82 pA, n=6) for total charge transfer (P=0.8336) (Fig. 3.4E). Since
it is not certain that the knockdown of STIM expression was 100% effective, I needed to
address the possibility that 3 µM thapsigargin may be sufficient to evoke an ER stress
response mediated by the residual STIM protein, post-knockdown. Therefore, these
recordings were repeated with 1 µM thapsigargin application instead of 3 µM. However,
large inward currents were nevertheless observed in response to this lower concentration
of Tg.
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Figure 3.4. Effect of knockdown of STIM1 & 2, via RNAi, on ER stress pannexin
currents in whole-cell patch-clamp recordings from hippocampal CA1 pyramidal
neurons.
A) Peak pannexin current was not altered in response to 3 µM thapsigargin B) nor in
response to 1 µM thapsigargin. C) Residual pannexin current after blockade with 100
µM lanthanum was not altered in response to 3 µM thapsigargin D) nor in response to 1
µM thapsigargin. E) Total charge transfer, as determined by area under curve of current
amplitude over time recording, was not altered in response to 3 µM thapsigargin F) nor in
response to 1 µM thapsigargin. Voltage was clamped at holding potential -60 mV.
Values are represented as mean ± SEM (STIM1&2 KD, n=5; scrambled, n=6). .
Statistical analysis: unpaired Student’s t-test, P < 0.05.
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ER stress evoked pannexin current is not Src-kinase dependent in neurons

My findings suggest that STIM is not required to facilitate ER stress induced pannexin
channel activation in cultured neurons. I therefore examined alternative candidate
mechanisms for promoting pannexin activation in neurons. In light of recently published
findings in which Src-family kinases were shown to mediate neuronal pannexin channel
activation induced by hypoxia (Weilinger et al., 2012), I decided to investigate the role of
Src-family kinases in ER stress induced pannexin activation. In the study from the
Thompson lab, inhibition of Src-family kinases was found to reduce pannexin current
size and cumulative charge transferred across the membrane during pannexin activation.
My experiment was designed to assess the requirement of Src by examining whether the
specific inhibition of Src can prevent the activation of pannexin channels in response to
ER stress inducer thapsigargin. To inhibit Src-family kinases, I used the drug PP2 at a
concentration of 10 µM in ECF, which was the effective concentration used by the
Thompson lab.
Unlike the results of the Thompson lab, my recordings do not show a reduction in peak
thapsigargin-evoked pannexin currents between Src-inhibitor treated (-1883 ± 188 pA,
n=6) and control recordings (-2352 ± 225 pA, n=5) (P=0.1399) (Fig. 3.5A). When
comparing residual current remaining after 100 µM lanthanum was applied, again there is
no difference between neurons treated with 10 µM PP2 (-986 ± 117 pA, n=6) and control
recordings (-823 ± 185 pA, n=5) (P=0.4588) (Fig. 3.5B). Finally, comparison of total
charge transfer, measured by area under the curve in these same recordings, was also the
same between 10 µM PP2 treated (-149 ± 112 pA, n=6) and control groups (-237 ± 60
pA, n=5) (P=0.5383) (Fig. 3.5C). The results of this experiment suggest the coupling of
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ER stress to pannexin channel activation in neurons is independent of phosphorylation by
Src-family kinases.
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Figure 3.5. Effect of Src-family kinase inhibition on ER stress induced pannexin
currents in whole-cell patch-clamp recordings from hippocampal CA1 pyramidal
neurons.
Recordings were performed in the presence of Src-family kinase inhibitor PP2 at 10 µM
in ECF. A) Peak pannexin current during 3 µM thapsigargin application was not altered
between Src-inhibtor and control groups. B) Residual pannexin current after blockade
with 100 µM lanthanum application was not altered between Src-inhibitor and control
groups. C) Total charge transfer, as determined by area under curve of current amplitude
over time recording, was not altered between Src-inhibtor and control groups. Voltage
was clamped at holding potential -60 mV. Values are represented as mean ± SEM (10
µM PP2, n=6; control, n=5). Statistical analysis: unpaired Student’s t-test, P < 0.05.
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ER stress evoked pannexin current is not caspase-dependent in neurons

After ruling out STIM and Src-family kinases as mediators of ER stress induced pannexin
activation in neurons, I examined whether yet another candidate mechanism was
responsible, namely caspase-mediated cleavage of the pannexin channel.

Indeed, a

previously identified pathway in pannexin activation during apoptosis by the
Ravichandran lab suggested that cleavage of the intracellular C-terminus of pannexin
channels by caspase 3 or caspase 7 was necessary to open the channel pore during
pannexin activation (Chekeni, 2010). Their use of intracellular 20 µM zVAD-FMK, a
commercially available caspase inhibitor, was effective in preventing pannexin current
from developing under apoptosis inducing conditions in jurkat cells expressing pannexin1 channels. My experiment was designed to observe the effects of inhibiting caspase 3
and caspase 7 in whole-cell recordings of ER stress induced pannexin currents in
neurons. To inhibit caspases 3 and 7, I used the same compound zVAD-FMK at a
concentration of 20 µM in my intracellular fluid (ICF) solution, which was the effective
concentration used by the Ravichandran lab.
In these recordings, application of 3 µM thapsigargin reliably evoked pannexin currents
as seen in control neurons.

Current size and sensitivity were identical to control

recordings. Additional recordings in neurons confirmed that 20 µM zVAD-FMK was
ineffective in preventing pannexin activation in response to thapsigargin. This suggests
that caspase cleavage is not required for ER stress induced pannexin activation.
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Figure 3.6. Effect of caspase inhibition on ER stress induced pannexin currents in
whole-cell patch-clamp recordings from hippocampal CA1 pyramidal neurons.
Both recordings were performed in the presence of caspase inhibitor, zVAD-FMK at 20
µM in ICF. Traces of recordings from preliminary trials demonstrating pannexin current
was not altered by caspase inhibitor in response to 3 µM thapsigargin. Pannexin currents
were identified by sensitivity to pharmacological pannexin blockers. Pannexin current
block by application of 100 µM lanthanum was not altered by the presence of
intracellular caspase inhibitor. Voltage was clamped at holding potential -60 mV.
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Summary of key findings

In this project, I investigated potential mechanisms underlying pannexin channel
activation in response to ER stress. Specifically, I explored the involvement of STIM
proteins in mediating this response and aimed to identify a critical domain that was
required to facilitate an interaction. I confirmed previous unpublished results from our
lab wherein ER stress inducers activated pannexin currents in neurons, in accordance
with the pharmacological profile of pannexin-1 channels. I then identified this activation
to be contingent on the recruitment of STIM in the HEK cell expression system.
Furthermore, I identified the ERM domain of STIM as a critical domain in activating
pannexin as suggested by the lack of pannexin current when overexpressing STIM
molecules with deleted ERM domains in HEK cells. In neurons, however, knockdown of
STIM proteins was not sufficient in abolishing ER stress induced pannexin currents as
noted by amplitude peak current, residual current as well as total charge transfer. Upon
exploring alternative mediators of ER stress induced pannexin activation, comparable
pannexin currents were evoked independent of Src-family kinases and cleavage by
caspases. To summarize the key results, pannexin activation in response to ER stress has
been established, however, a molecular mechanism underlying this activation has been
demonstrated in HEK cells but not yet in neurons.

4.2

Pannexin channel activation in response to ER stress

Using whole-cell voltage-clamp recordings of pannexin currents from cultured pyramidal
CA1 neurons of mouse hippocampus, ER stress was induced by acute treatment with
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commonly used ER stressors. Our lab has used 3 different inducers of ER stress, namely,
SERCA pump inhibitors thapsigargin and cyclopiazonic acid as well as N-glycosylation
inhibitor tunicamycin. Each of these agents has been shown to reliably induce ER stress
in a number of different systems (Tobmal et al., 2000; Lehrman, 2001; Pirot et al., 2006).
These agents all act upon the ER and are thought to provoke the accumulation of
misfolded proteins in the ER. This occurs either as a consequence of disrupting ER Ca2+
homeostasis (thapsigargin and cyclopiazonic acid) or by interfering with glycosylation
(tunicamycin), both of which are necessary for regulated protein folding in the ER. The
consequent accumulation of unprocessed proteins, brought on by the disruption in Ca2+
homeostasis and misfolding of proteins within the ER, initiates ER stress (Michalek et al.,
2002). These three pharmacological ER stress inducers have been shown by our lab to
reliably produce pannexin channel activation (Appendix A S1A). In a first series of
experiments, I have confirmed the activation of pannexin channels by the ER stressor,
thapsigargin. I was able to reproduce this result in cultured pyramidal neurons from the
CA1 region of mouse hippocampus. Acute extracellular application of 3 µM thapsigargin
while recording from whole-cell patch-clamped cells, consistently evoked a 2000-3000
pA current that could be reversibly blocked with the application of 100 µM lanthanum
(Figure 3.1).

Stemming from the lack of a specific blocker for pannexin channels, a common criticism
towards pannexin channel identification is in the certainty that the recorded current is in
fact pannexin.

Accordingly, our lab has extended this result over the known

pharmacological profile of pannexin channels to positively identify the currents generated
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as being pannexin mediated. Thus, we have shown these currents to be sensitive to
lanthanum, carbenoxolone, probenecid, 10panx peptide, as well as insensitive to the ORAI
and TRPC channel blocking compound, SKF96365; and also the connexin and TRPM
blocking condition, calcium-free extracellular recording solution.

The resulting

pharmacological profile uniquely identifies pannexins channels as being responsible for
ER stress activated currents.

4.3

ER stress-pannexin coupling modelled in neurodegenerative disease

Although pharmacological inducers provide a reliable experimental means of modeling
ER stress, the next step was to demonstrate the relevance of ER stress induced pannexin
activation in neurological disease. My objective was to extend these findings by
determining whether pannexin activation is observed in neurological disease where ER
stress is known to occur. ER stress has been demonstrated in response to exposure of
cultured neurons to Aβ42. In terms of the molecular players involved, the three branches
of the UPR start with activating-transcription-factor-6 (ATF6), protein-kinase-RNA-likeER-kinase (PERK), and inositol-requiring-enzyme-1 (IRE1). In the absence of ER stress,
BiP, also an ER resident protein, remains bound to PERK, IRE1, and ATF6, suppressing
their signaling activity.

However, when the protein folding capacity of the ER is

exhausted and umisfolded proteins accumulate, BiP dissociates from its binding partners
and binds to misfolded proteins, initiating the UPR (Schroder and Kaufman, 2005).
These three active constituents (ATF6, PERK, IRE1) and BiP are typically screened for
as markers of ER stress.
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Previous studies have shown increases in UPR markers such as PERK, IRE1, ATF6 and
BiP in response to Aβ42 application (Katayama et al., 2003; Ferreiro et al., 2006; Seyb et
al., 2006). The aforementioned findings of my earlier experiments showing ER stress
coupled pannexin activation provided a rationale for me to investigate whether ER stress
by Aβ42 can promote pannexin channel activation.

In these experiments, I showed

constitutive activation of pannexin channels in response to 24 hours of pre-treatment with
Aβ42.

Currents recorded upon initial breakthrough during whole-cell voltage-clamp

recordings were significantly larger than those in the vehicle treated group (Figure 3.2C).
Recorded currents were identified as pannexin currents based on their sensitivity to 100
µM lanthanum blockade as well as their lack of sensitivity to other channel blockers

contained in recording solutions (TEA, TTX, CNQX, bicuculline, 4-AP, nifedipine).
This finding is the first to demonstrate pannexin channels activation in a model of
Alzheimer’s Disease.

Thus far, I have not defined a role for pannexin channels in the context of
neurodegeneration. Given the previous implications of pannexin channels mediating cell
death and inflammation, it is conceivable that pannexin channels could be functioning in
a similar role in Alzheimer’s Disease. Whether or not pannexin channels contribute to
Aβ42 induced neurotoxicity remains to determined. Therefore, a follow-up experiment to
this study would be to examine if the absence of pannexin channels, either by knockdown
or knockout, reduces neuronal cell death in this model. This can be assessed using either
an MTT assay to measure cell viability based on metabolic activity, or using live/dead
staining to assay for membrane integrity.
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Molecular basis for pannexin activation during ER stress

The primary objective of my study was to establish the mechanisms through which ER
stress provokes pannexin activation. I hypothesized that pannexin channel activation
during ER stress is contingent on recruitment of STIM proteins. My electrophysiological
data in transfected HEK 293 cells was strongly in favour of my hypothesis. Only cells
transfected with full length STIM and inducibly expressed pannexin-1 had ER stress
evoked currents that were pharmacologically identified as pannexin currents (Fig. 3.2).
In contrast, the cells transfected with an empty vector or just GFP, for visual confirmation
of transfection efficiency, were not able to generate a pannexin current in response to
pharmacological ER stress induction. This group portrayed the absence of STIM and
made it evident that ER stress induced pannexin activation was contingent on the
recruitment of STIM. In these experiments, it was expected that depletion of ER Ca2+
allowed Ca2+ to dissociate from the intraluminal N-terminal E-F binding hands of STIM,
normally maintained as homodimers at rest when the ER is replenished. The dissociation
of Ca2+ provokes a conformational change that releases the auto-inhibitory domain of
STIM from binding to itself. This activates STIM proteins and allows them to
oligomerize and translocate as a cluster to regions of the ER that are in close proximity to
the plasma membrane. Within these ER-plasma membrane junctions we propose that
STIM proteins physically interact with plasma membrane bound pannexin channels to
promote their activation. Precedence for the interaction of STIM with plasma membrane
channels has been established in the context of ORAI activation during store-operated
Ca2+ entry, as modeled in Figure 4.1.
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Figure 4.1
Schematic model of STIM-ORAI interaction during store-operated
Ca2+ entry
Upon ER-Ca2+ store depletion, STIM oligomerizes and translocates towards ER-PM
junctions where it interacts with and activates Ca2+ permeable ORAI channels to
replenish ER-Ca2+ stores. (Modified from Roos et al., 2005)

In this context, recent evidence suggested STIM proteins not only participate in storeoperated Ca2+ entry to regulate ER Ca2+ refilling but may also function more broadly as a
sensor for ER stress (Soboloff et al., 2011). Independent of ER Ca2+ depletion, STIM
activated by reactive oxygen species (ROS) couples to ORAI channels suggesting STIM
also functions as a sensor of oxidative stress (Hawkins et al., 2010). Additionally,
cellular stress from transient temperature variation can also induce STIM-ORAI coupling
independent of ER Ca2+ depletion (Xiao et al., 2011). Upon further review of the
literature describing ORAI channel activation during store-operated Ca2+ entry, it has
been reported that the Ca2+-channel activating domain (CAD) region of STIM1, residues
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342-348, is sufficient to constitutively activate ORAI channels (Park et al., 2009). In its
resting conformation, the CAD region of STIM1 is auto-inhibited by intramolecular
electrostatic interactions. Activation of STIM triggers conformational changes exposing
the acidic residues of the CAD region to interact with the basic sequences on ORAI
(Wang et al., 2010). This information led me to investigate whether the CAD region of
STIM was crucial in activating pannexin channels during ER stress, analogous to its role
in activating ORAI channels during store-operated Ca2+ entry. Experimentally, I needed
a system where mutated STIM proteins, with deleted CAD regions, could be expressed.
Therefore, instead of recording in cultured neurons where I could not readily control
STIM expression levels, I again used HEK cells expressing pannexin-1 (doxycyclineinducible) where I could transiently transfect DNA encoding for mutated STIM proteins.
First, I demonstrated that in the absence of transient expression of STIM, thapsigarginevoked pannexin-1 currents are absent in these cells (Figure 3.3A), a result I reproduced
from previous Jackson/MacDonald lab data (Appendix A S3). One control experiment
that remains to be completed is the recording of ER stress induced current in HEK cells
expressing STIM but not expressing pannexin-1, an experiment where we do not expect
current to be evoked.

To advance that finding, I recorded panx1 currents in response to 3 µM thapsigargin in
HEK cells expressing pannexin-1 (induced with doxycycline) with transient transfection
of mutated STIM1 whereby the ERM domain of STIM1, which contains the CAD region,
was deleted from the full-length protein (STIM1ΔERM).

The lack of current that

developed in the STIM1ΔERM group compared to the full length STIM group provided
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evidence that the ERM domain is a critical domain in mediating the coupling of ER stress
to pannexin activation (Figure 3.3D).

This experiment reinforces the notion that a

physical interaction may exist between active oligomeric STIM complexes and pannexin
channels on the plasma membrane, analogous to the well-established interaction between
active oligomeric STIM complexes and ORAI channels on the plasma membrane.
Whether such an interaction between STIM and pannexin is direct or indirect, via a
macromolecular complex, is yet to be determined and provides a rationale for future coimmunoprecipitation experiments on STIM-pannexin as well as CAD-pannexin in a
model of ER stress.

4.5

Contribution of STIM proteins to pannexin channel activation in neurons

After demonstrating ER stress induced pannexin activation pharmacologically and also
with Aβ42, I sought to identify the underlying mechanisms which couple ER stress to
pannexin activation in neurons. My own results suggest that STIM, and more specifically
its ERM domain, is required for pannexin activation in HEK cells in response to
treatment with ER stressors. This led me to predict that a knock down of STIM proteins
in neurons would abolish ER stress induced pannexin currents. To test this idea, I
recorded in neurons which had been lentiviral infected with DNA encoding for short
RNA hairpins targeting STIM transcripts (shRNASTIM1 and shRNASTIM2) to knockdown
expression of STIM proteins. Separate biochemical experiments from sister cultures
infected in parallel confirmed the reduction of STIM expression (Appendix A S4).
Opposing the prediction, thapsigargin-induced pannexin currents were evoked in STIM
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knockdown neurons with no difference observed in peak current, residual current after
100 µM lanthanum block or total charge transferred across the plasma membrane
between the knockdown and the scrambled shRNA groups (Figure 3.4 A, C, E). It was
conceivable that 3 µM thapsigargin was a high enough concentration to evoke an ER
stress response mediated by only the residual STIM (10-30% of control levels) left
behind after shRNA knockdown. For this reason, I repeated the experiment using a lower
dose, 1 µM thapsigargin. However, pannexin currents of similar size and progression
were evoked under the low dose as well, indicating the response was not dose-dependent
at thapsigargin concentrations greater than 1 µM (Figure 3.4 B, D, F).

When interpreting the functional consequence of this result, at face value the result of my
STIM-KD experiment in neurons (Figure 3.4) suggests that natively expressed STIM
does not contribute to pannexin channels activation in response to Thapsigargin treatment
of cultured hippocampal neurons. One pitfall of the approach utilized is that recordings
may have been made from neurons in which less than complete knockdown of STIM has
been achieved. To maximize the likelihood of recording only from certain successfully
infected neurons, each lenti-transfer vector, used to express shRNA sequences, also
allowed expression of different fluorescent marker (GFP and RFP). shRNASTIM1 was coexpressed with GFP and shRNASTIM2 was co-expressed with mCherry. By selecting
only neurons that were GFP-positive as well as mCherry-positive, I could confirm that
the neurons I recorded from did express both shRNA variants. Using this criteria I
observed an infection efficiency of 90-100% in cultured neurons. Our western blot data
suggests substantial reduction (~70-90%) in STIM1&2 after lentiviral shRNA infection,
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however, detection in western blotting is not as sensitive as electrophysiological
recordings, nor does it show any functional consequence. Though in reduced amounts,
STIM may have still been expressed enough to observe functionality in whole-cell
recordings. Therefore, it is possible that the level of reduction by our shRNASTIM1/2 was
not sufficient in abolishing STIM function.

This result could be influenced by many factors including the limited effectiveness of
shRNA in achieving complete knockdown and/or the overexpression of visual fluorescent
markers increasing cellular stress and promoting pannexin activation as part of an
inflammatory response. Although several interpretations to this negative result can be
inferred, ultimately, this finding led me to consider alternative candidate mechanism
underlying ER stress induced pannexin activation.

4.6

Exploring alternative mechanisms of pannexin activation in neurons

A recent study demonstrating anoxia-induced pannexin currents employed Src-family
kinase inhibitor PP2 to prevent pannexin currents by blocking tyrosine phosphorylation at
the pannexin c-terminus mediated by NMDA-receptor activation (Weilinger et al., 2012).
In this study done by the Thompson lab, upon anoxia-induced pannexin activation, initial
depolarization, residual current after block and cumulative charge transfer were analyzed.
Residual current after block, which represents non-pannexin mediated activity, and
cumulative charge transferred were significantly reduced in PP2-treated groups compared
to vehicle treated. This study was performed in a model of anoxia, a well-known model
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for generating ER stress (Bodalia et al., 2012), thus providing rationale for consideration
as a candidate mechanism underlying the ER stress-induced model of pannexin activation
I have presented. Furthermore, recent evidence demonstrating the activation of Srcfamily kinases in response to ER stress (Yu and Kim, 2010) has made Src a candidate to
be investigated as a mediator of ER stress induced pannexin activation.

In this experiment, pannexin currents were recorded in response to 3 µM thapsigargin in
the presence of 10 µM PP2, an inhibitor of Src-family kinases, applied extracellularly
through the bath solution. These recordings were from isolated pyramidal neurons of the
mouse CA1 hippocampus region. The results show that ER stress-induced pannexin
currents were still evoked in the presence of a Src-family kinase inhibitor. In accordance
with the results from the Thompson lab, the same parameters were quantified and
analyzed.

However, there was no difference found in the peak current amplitude,

residual current after block with 10 µM lanthanum or total charge transferred across the
membrane between Src-kinase inhibitor and vehicle treated groups (Fig. 3.5). This result
has yet to be supported in our lab with data from phosphorylation assays to determine the
effectiveness of extracellular 10 µM PP2 in inhibiting tyrosine phosphorylation under ER
stress.

This discrepancy in outcomes suggests that the underlying mechanism of

pannexin activation is likely to be modality specific. Although the literature suggests an
overlap in activation pathways, I have demonstrated that ER stress-induced pannexin
activation and anoxia-induced pannexin activation are not dependent on the same
signaling molecules.
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A recent study by the Ravichandran lab, published in 2010, identified yet another
potential mechanisms provoking pannexin channel activation.

They showed that

pannexin-1 is a target for caspase 3 and 7. They identified a specific caspase-cleavage site
at the C-terminus of pannexin-1. Cleavage at this site was essential for pannexin
activation during apoptosis. A truncated variant of pannexin-1, truncated at its caspasecleavage site at the C-terminus, resulted in constitutive activation whereas
pharmacological inhibition of caspases 3 and 7 inhibited activation of wild type
pannexin-1 (Chekeni et al., 2010). The findings of this study provided me with an
alternative candidate mechanism for pannexin activation.

Given that ER stress has

previously been shown to lead to caspase activation (Nakagawa et al., 2000), I reasoned
that activation of caspases and their subsequent cleavage of pannexin c-terminal may
provide a mechanism for pannexin activation. For this experiment, I recorded pannexin
currents in response to 3 µM thapsigargin in the presence of 20 µM zVAD-fmk, an
inhibitor of caspases 3 and 7, applied intracellularly through the patch electrode, as
performed by the Ravichandran lab. I recorded from isolated pyramidal neurons of the
mouse CA1 hippocampus region. My preliminary observations convincingly show ER
stress induced pannexin activation even in the presence of caspase inhibitor (Fig. 3.6).
Although more replicates need to be done before reporting a conclusive result, it appears
caspase-cleavage does not contribute to pannexin channel activation under the modality
of ER stress. This result has yet to be supported in our lab with data from experiments
testing caspase activity to determine the effectiveness of intracellular 20 µM zVAD-FMK
in inhibiting caspase activity during ER stress.
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This finding did however reinstate the view that pannexin activation has modality
specific mechanisms. This view is supported by the divergence between ER stressinduced and apoptosis-induced pannexin activation in addition to the previously
described divergence from anoxia-induced pannexin activation.

4.7

Experiments for future studies

I hypothesized that pannexin channel activation during ER stress is contingent on
recruitment of STIM proteins. This was primarily supported by results in HEK 293 cells
where expression of STIM is necessary to reconstitute pannexin channel activation in
response to thapsigargin application. In this model system, my results using a STIM
deletion construct suggests that the ERM domain of STIM, which includes the CAD
activating domain necessary for STIM-coupling to ORAI channels, is also necessary for
pannexin channel activation by ER stress.

Given this finding and considering the

relatively large size (286 amino acids) of the ERM domain, a follow-up experiment
would be to delete only the CAD domain (STIM1ΔCAD), rather than the entire ERM
domain, to prove that CAD alone is the region interacting with pannexin channel and that
this interaction does not involve other components of the ERM.

If the result is positive (ie. Panx1 current is abolished in STIM1ΔCAD transfected HEK
cells), the next objective would be to determine whether the CAD domain of STIM1 is
sufficient to activate pannexin-1 by transfecting only the CAD domain fragment (rather
than full-length STIM1 with a deleted CAD domain) into HEK 293 cells and recording
for constitutively active panx1 currents. A positive result in this experiment (ie. ERM
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fragment is sufficient to activate panx1 channels), would provide further support for my
hypothesis in the context of HEK cells where ER stress induced pannexin activation is
mediated by STIM.

Additionally, this positive result would show that pannexin

activation is not only achieved using pharmacological ER stress inducers but also by the
constitutively active form of an ER stress sensing protein.

Since ERM and CAD

fragments would no longer be attached to the intraluminal calcium binding E-F hands of
STIM, these fragments would be useful tools in modeling constitutively active STIM.
This would refute any criticism that non-specific pharmacological ER stressors may be
activating other cellular processes that could contribute to the observed response.

Another interpretation of the negative electrophysiological result in the STIM-KD
experiment is that STIM proteins do not play a role in neuronal ER stress induced
pannexin activation. To consider this interpretation, we need a positive control to
functionally confirm the knock down of STIM proteins upon lentiviral infection of
shRNASTIM1&2.

This can be confirmed by using calcium imaging to assay for store-

operated calcium entry after the shRNA knock down of STIM. Since store-operated Ca2+
entry is contingent on STIM proteins we should not observe any store-operated Ca2+
entry in shRNASTIM1&2 infected neurons (Liou et al., 2005; Roos et al., 2005). This result
would add confidence in the negative finding resulting from STIM knockdown
experiments and would allow me to reject my hypothesis of STIM-pannexin coupling in
the context of neuronal ER stress induced pannexin activation. To avoid skepticism
towards effectiveness of the knock down, an ideal experiment to test my hypothesis
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would be to record ER stress induced pannexin activation in neurons from STIM
knockout mice.

A recent study highlighting pannexin involvement in an in vivo model of cerebral
ischemia used pannexin-1-/-, pannexin-2-/- and pannexin-1-/-pannexin-2-/- knockout mice
to determine the contribution of each form to neuronal cell death. Interestingly,
pannexin-1-/-pannexin-2-/- knockout mice demonstrated smaller infarct sizes and increased
cell viability, whereas damage in pannexin-1-/- and pannexin-2-/- was the same as in wildtype mice (Bargiotas et al., 2011). To further my own findings, I would record ER stress
induced currents from pannexin-1 knockout mice to understand whether or not there is
any contribution by pannexin-2 to the aforementioned ER stress induced pannexin
activation.

Furthermore, now that I have shown pannexin activation in response to Aβ42 treatment, a
future study would be to repeat that experiment in neuronal cultures from pannexin-1
knockout mice. I would expect the constitutive current observed at the onset of the
recording to be abolished.

This would provide rationale for a cell death assay to

investigate the relative Aβ42-mediated neurotoxicity in pannexin-1 knockout neurons
compared to wild-type neurons. This set of experiments would add to the significance of
the project by characterizing a role for pannexin channel activation in AD.
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Significance of the study

The importance of my study is highlighted by the limited information on the regulation of
pannexin channel activity.

Despite numerous findings of novel pannexin channel

function, very few studies have examined molecular mechanisms underlying pannexin
activation. My findings do not refute any of the previous implications for pannexin
channel involvement in various pathophysiological conditions; rather it adds another
possible mechanism of activation for the field to consider.

In this project, I have

established ER stress as a means of activating pannexin channels, not to be
misunderstood for proposing a novel function of pannexin channels. Accordingly, my
finding implicates pannexin channels as a downstream mediator of the ER stress
response. It is entirely possible that the pannexin activation demonstrated by other groups
in various contexts including inflammation, apoptosis and hypoxia is a downstream effect
of the ER stress that is associated with these conditions.

Broader implications of my study stem from the involvement of ER stress in
neurodegeneration.

By presenting evidence of pannexin activation in a model of

Alzheimer’s Disease, the contribution of pannexin channels to neurotoxicity and the
disruption of the ER stress-pannexin coupling in neurodegeneration becomes a focal
point for future projects.
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Appendix A: Supplementary Figures

A)

B)

Figure S1. Unpublished lab data illustrating A) various pharmacological ER stress
inducers activating La3+ sensitive currents in neurons. B) Pharmacological profile of
ER stress induced currents rule-in pannexin channels and rule-out other nonselective cation channels in neurons.
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Figure S2. Unpublished lab data. Western blot characterization of Aβ42 oligomers
composed as trimers and tetramers.
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Figure S3. Unpublished lab data illustrating that complete reconstitution of
thapsigargin-evoked current in HEK cells requires co-transfection of pannexin-1
and either STIM1 or STIM2.
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Figure S4. Unpublished lab data demonstrating the effectiveness of RNAi
knockdown of STIM1 and STIM2, following lentiviral infection in neurons, by
Western blot and quantified densitometrically (normalized to β-actin).

	
  

	
  

	
  

81

Appendix B: Curriculum Vitae
Ankur Bodaila
Education
Western University: Masters of Science in Pharmacology and Toxicology
Sept. 2011- Sept. 2013
Thesis:
ER stress coupled pannexin activation via STIM proteins
Supervisors:
Drs. Michael F. Jackson and John F. MacDonald
Western University: Bachelor of Sciences (Honors Specialization in Medical Sciences)
Sept. 2007 – Apr. 2011
Scholarships and Awards
First Place – Neuroscience & Mental Health – London Health Research Day 2013
Mar. 2013
o Poster presentation titled “ER stress induced pannexin activation via STIM coupling”
Western University Graduate Thesis Research Award – Travel Scholarship
Jan. 2013
o Value: $500
Duration: Jan. 2013 – Aug. 2013
Alzheimer’s Foundation of London and Middlesex Scholarship – M.Sc. Award
Nov. 2012
o Value: $12 500
Duration: Sept. 2012 – Aug. 2013
First Place – Neuroscience – Dept. of Physiology & Pharmacology Research Day
Nov. 2012
o Poster presentation titled “ER stress induced pannexin activation via STIM coupling”
Teaching Experience
Western University – Department of Physiology & Pharmacology
2012-2013
Mammalian Physiology 3130Y – Course Coordinator: Thomas Stavraky
2011-2012
Mammalian Physiology 3130Y – Course Coordinator: Thomas Stavraky
Publications
Bodalia A, Li H, Jackson MF (2012) Loss of endoplasmic reticulum Ca2+ homeostasis:
contribution to neuronal cell death during cerebral ischemia. Acta Pharmacologica Sinica.
34(1): 49-59. Review.

	
  

